Stimulant Treatment for Childhood ADHD Not Linked to Substance Use
TUESDAY, July 11, 2023 (HealthDay News) — For children with attention-deficit/hyperactivity disorder (ADHD), stimulant treatment is not associated with later frequent substance use by adolescents and young adults, according to a study published onlin…
Learn MoreP2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
MONDAY, July 10, 2023 (HealthDay News) — For patients with coronary artery disease (CAD), P2Y12 inhibitor monotherapy is associated with a lower risk for cardiovascular death, myocardial infarction, and stroke compared with aspirin monotherapy, accor…
Learn MoreP2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
MONDAY, July 10, 2023 (HealthDay News) — For patients with coronary artery disease (CAD), P2Y12 inhibitor monotherapy is associated with a lower risk for cardiovascular death, myocardial infarction, and stroke compared with aspirin monotherapy, accor…
Learn MoreMenos niños reciben recetas de antipsicóticos
VIERNES, 7 de julio de 2023 (HealthDay News) — El uso de antipsicóticos en los niños sigue en descenso, probablemente debido a unas mejores políticas y a la educación, muestra una investigación reciente. El estudio encontró una reducción de un 43 por…
Learn MoreVariation Seen in Dosing of Meds at Prehospital Pediatric Encounters
MONDAY, July 10, 2023 (HealthDay News) — For pediatric patients in the prehospital setting, weight-based dosing often varies from national guidelines, according to a study published online July 10 in Pediatrics.Sriram Ramgopal, M.D., from the Northwe…
Learn MoreIn Study, Almost Half of Obese Teens Were No Longer So After Taking Wegovy/Ozempic
MONDAY, July 10, 2023 (HealthDay News) — The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too.This trial, funded by drug maker Novo Nordisk,…
Learn MoreTherapeutic Value of Drugs Lower for Supplemental Versus First Indications
FRIDAY, July 7, 2023 (HealthDay News) — For drugs approved in the United States and Europe, the therapeutic value of supplemental indications is lower than for first indications, according to a study published online July 5 in The BMJ.Kerstin N. Voki…
Learn MoreMirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
FRIDAY, July 7, 2023 (HealthDay News) — For patients with moderately-to-severely active ulcerative colitis, mirikizumab is more effective than placebo for inducing and maintaining clinical remission, according to a study published in the June 29 issu…
Learn MoreFewer Kids Are Being Prescribed Antipsychotic Meds
FRIDAY, July 7, 2023 (HealthDay News) — The use of antipsychotic medication in children is continuing to plummet, likely because of better policies and education, new research shows.The study found a 43% drop in antipsychotic prescriptions for Medica…
Learn MoreLong-Acting ART Achieves Virologic Suppression for People With HIV
WEDNESDAY, July 5, 2023 (HealthDay News) — Long-acting antiretroviral therapy (LA-ART) can achieve virologic suppression among people with HIV (PWH), including those with viremia, according to a study published online July 4 in the Annals of Internal…
Learn More